

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.86070701 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.62830920 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.35053708 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.35053708 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.98355329 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.98355329 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.77891250 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.58508168 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.35930368 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.94512750 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.94512750 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.94512750 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.81844418 |
| 14 | drug metabolic process (GO:0017144) | 5.76673865 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.68330604 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.61476120 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56534437 |
| 18 | urea cycle (GO:0000050) | 5.50028991 |
| 19 | urea metabolic process (GO:0019627) | 5.50028991 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.43831705 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.42799059 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.30583340 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.22977147 |
| 24 | protein carboxylation (GO:0018214) | 5.22977147 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.18888907 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.17169630 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.16082309 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.11716180 |
| 29 | cysteine metabolic process (GO:0006534) | 5.09950849 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.04006397 |
| 31 | bile acid metabolic process (GO:0008206) | 4.94713686 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.89895968 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.84755929 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.83351982 |
| 35 | regulation of complement activation (GO:0030449) | 4.81422293 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.80560644 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.79473923 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.76635965 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.73559294 |
| 40 | ethanol metabolic process (GO:0006067) | 4.72669213 |
| 41 | phospholipid efflux (GO:0033700) | 4.69968795 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.69269980 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.69269980 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.69269980 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.65799715 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.65799715 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.63576263 |
| 48 | oxidative demethylation (GO:0070989) | 4.55053167 |
| 49 | bile acid and bile salt transport (GO:0015721) | 4.53420040 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.47754101 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.47754101 |
| 52 | lysine metabolic process (GO:0006553) | 4.42225505 |
| 53 | lysine catabolic process (GO:0006554) | 4.42225505 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.41934757 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.41864734 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.31075284 |
| 57 | cholesterol efflux (GO:0033344) | 4.27438578 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.26642805 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.25473081 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.20410530 |
| 61 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.20307018 |
| 62 | hormone catabolic process (GO:0042447) | 4.19155425 |
| 63 | negative regulation of hemostasis (GO:1900047) | 4.18997973 |
| 64 | negative regulation of blood coagulation (GO:0030195) | 4.18997973 |
| 65 | regulation of plasminogen activation (GO:0010755) | 4.17975171 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.16544521 |
| 67 | cellular glucuronidation (GO:0052695) | 4.15961855 |
| 68 | amine catabolic process (GO:0009310) | 4.11984347 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 4.11984347 |
| 70 | intestinal cholesterol absorption (GO:0030299) | 4.08564874 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.07067875 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 4.06312280 |
| 73 | glycine metabolic process (GO:0006544) | 4.05426512 |
| 74 | negative regulation of protein activation cascade (GO:2000258) | 4.04554582 |
| 75 | glutamate metabolic process (GO:0006536) | 4.02682071 |
| 76 | flavonoid metabolic process (GO:0009812) | 4.00829632 |
| 77 | acute-phase response (GO:0006953) | 4.00811325 |
| 78 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.98542813 |
| 79 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.98542813 |
| 80 | drug catabolic process (GO:0042737) | 3.97031860 |
| 81 | regulation of bile acid biosynthetic process (GO:0070857) | 3.96166288 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 3.96006086 |
| 83 | phenylpropanoid metabolic process (GO:0009698) | 3.91715735 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 3.90073341 |
| 85 | regulation of humoral immune response (GO:0002920) | 3.88929442 |
| 86 | serine family amino acid metabolic process (GO:0009069) | 3.87468350 |
| 87 | alkaloid metabolic process (GO:0009820) | 3.87007686 |
| 88 | negative regulation of coagulation (GO:0050819) | 3.86990418 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 3.83951717 |
| 90 | fibrinolysis (GO:0042730) | 3.82989442 |
| 91 | ethanol oxidation (GO:0006069) | 3.82290209 |
| 92 | cholesterol homeostasis (GO:0042632) | 3.81712904 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.80430529 |
| 94 | arginine metabolic process (GO:0006525) | 3.80053941 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.79004751 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78891931 |
| 97 | intestinal absorption (GO:0050892) | 3.78545457 |
| 98 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.77811216 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.75887032 |
| 100 | sterol homeostasis (GO:0055092) | 3.75695764 |
| 101 | negative regulation of wound healing (GO:0061045) | 3.75685252 |
| 102 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73871347 |
| 103 | serine family amino acid biosynthetic process (GO:0009070) | 3.72301469 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.68571157 |
| 105 | glucuronate metabolic process (GO:0019585) | 3.68571157 |
| 106 | protein-lipid complex assembly (GO:0065005) | 3.66797814 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.65240270 |
| 108 | complement activation, classical pathway (GO:0006958) | 3.62676646 |
| 109 | ketone body metabolic process (GO:1902224) | 3.62610725 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.61434312 |
| 111 | lipoprotein metabolic process (GO:0042157) | 3.60851537 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.60751260 |
| 113 | cofactor catabolic process (GO:0051187) | 3.60540101 |
| 114 | organic acid catabolic process (GO:0016054) | 3.60006129 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 3.60006129 |
| 116 | blood coagulation, intrinsic pathway (GO:0007597) | 3.59259700 |
| 117 | complement activation (GO:0006956) | 3.58034462 |
| 118 | protein activation cascade (GO:0072376) | 3.56667149 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.54807836 |
| 120 | opsonization (GO:0008228) | 3.50823184 |
| 121 | cytolysis (GO:0019835) | 3.49702469 |
| 122 | drug transmembrane transport (GO:0006855) | 3.48532302 |
| 123 | regulation of apoptotic cell clearance (GO:2000425) | 3.46480961 |
| 124 | response to mercury ion (GO:0046689) | 3.40549388 |
| 125 | polyketide metabolic process (GO:0030638) | 3.37621863 |
| 126 | doxorubicin metabolic process (GO:0044598) | 3.37621863 |
| 127 | daunorubicin metabolic process (GO:0044597) | 3.37621863 |
| 128 | negative regulation of complement activation (GO:0045916) | 3.37406371 |
| 129 | angiotensin maturation (GO:0002003) | 3.33104958 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 3.31591877 |
| 131 | primary alcohol catabolic process (GO:0034310) | 3.29580867 |
| 132 | positive regulation of blood coagulation (GO:0030194) | 3.27745207 |
| 133 | positive regulation of hemostasis (GO:1900048) | 3.27745207 |
| 134 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.26892972 |
| 135 | xenobiotic metabolic process (GO:0006805) | 3.24703737 |
| 136 | drug transport (GO:0015893) | 3.24622834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.16163280 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.98748510 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.72549481 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41224172 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.08886896 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.86515802 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.66072514 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.09900620 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.74628840 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.07061535 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00338735 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4412171 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97492677 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72853306 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72150549 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70099691 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.68716261 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64315311 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56353348 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47490504 |
| 21 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44828394 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40624382 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28601189 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20750414 |
| 25 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19978257 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10916578 |
| 27 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10255384 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09785611 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07896009 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03652008 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03327001 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02509001 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00978143 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98867388 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95069697 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94187389 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92057097 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91286162 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89454840 |
| 40 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89021810 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88202715 |
| 42 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.86223183 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84725195 |
| 44 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83264777 |
| 45 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83049600 |
| 46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80839183 |
| 47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80839183 |
| 48 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80596060 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80152143 |
| 50 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79558902 |
| 51 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79451200 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79426963 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79426963 |
| 54 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.79400865 |
| 55 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.79239302 |
| 56 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77575844 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76784675 |
| 58 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75528065 |
| 59 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74342927 |
| 60 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74076259 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.74064718 |
| 62 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.72451390 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72381255 |
| 64 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.71034766 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71014269 |
| 66 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.68812810 |
| 67 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68550212 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.68539459 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.68521903 |
| 70 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67883443 |
| 71 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.67538265 |
| 72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66950662 |
| 73 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66739079 |
| 74 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65852077 |
| 75 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65418672 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.64520862 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.63720651 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62950172 |
| 79 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.62463811 |
| 80 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62241661 |
| 81 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.62186456 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61802157 |
| 83 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.61039777 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 0.61017363 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60794939 |
| 86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.60600449 |
| 87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59959446 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.59837849 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.58975010 |
| 90 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58848687 |
| 91 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.58549300 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58027569 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57639673 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.56762652 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56343320 |
| 96 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56310817 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55658582 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.54842527 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54190550 |
| 100 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53979820 |
| 101 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53259198 |
| 102 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52150394 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.51931798 |
| 104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.51824711 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51597075 |
| 106 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.51011352 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.50997518 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.50772607 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.50521489 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.49251297 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48563972 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48521684 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47292565 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47257480 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.47251575 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.46846555 |
| 117 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.46521670 |
| 118 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46509085 |
| 119 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44845116 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44687341 |
| 121 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.44643558 |
| 122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.44115341 |
| 123 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43574698 |
| 124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42232456 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41282783 |
| 126 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.40870637 |
| 127 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40177591 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39982418 |
| 129 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.39203836 |
| 130 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.38575579 |
| 131 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.37569442 |
| 132 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37263768 |
| 133 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.37172775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17091069 |
| 2 | MP0005360_urolithiasis | 7.53174706 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.33283910 |
| 4 | MP0005365_abnormal_bile_salt | 6.03642725 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.94061114 |
| 6 | MP0003252_abnormal_bile_duct | 4.11646124 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.04973216 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57129676 |
| 9 | MP0009840_abnormal_foam_cell | 3.28993896 |
| 10 | MP0005083_abnormal_biliary_tract | 2.98078519 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.95459222 |
| 12 | MP0003195_calcinosis | 2.94035431 |
| 13 | MP0005332_abnormal_amino_acid | 2.64481960 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.27812146 |
| 15 | MP0000609_abnormal_liver_physiology | 2.14326757 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.12690409 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.09518094 |
| 18 | MP0003868_abnormal_feces_composition | 1.96386963 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.90380621 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.76146124 |
| 21 | MP0001764_abnormal_homeostasis | 1.61988226 |
| 22 | MP0009697_abnormal_copulation | 1.55557021 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43486644 |
| 24 | MP0005451_abnormal_body_composition | 1.38070799 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.34103705 |
| 26 | MP0003879_abnormal_hair_cell | 1.28618713 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.27268280 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.17451433 |
| 29 | MP0000598_abnormal_liver_morphology | 1.13294374 |
| 30 | MP0003011_delayed_dark_adaptation | 1.12557567 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.11014648 |
| 32 | MP0003186_abnormal_redox_activity | 1.08863207 |
| 33 | MP0002254_reproductive_system_inflammat | 1.04518068 |
| 34 | MP0005647_abnormal_sex_gland | 1.03631504 |
| 35 | MP0005670_abnormal_white_adipose | 0.97364929 |
| 36 | MP0009764_decreased_sensitivity_to | 0.95848945 |
| 37 | MP0009763_increased_sensitivity_to | 0.94137452 |
| 38 | MP0000604_amyloidosis | 0.94016109 |
| 39 | MP0005220_abnormal_exocrine_pancreas | 0.93117479 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 0.92611239 |
| 41 | MP0002132_abnormal_respiratory_system | 0.92406418 |
| 42 | MP0004272_abnormal_basement_membrane | 0.91957952 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 0.91653972 |
| 44 | MP0002078_abnormal_glucose_homeostasis | 0.91320669 |
| 45 | MP0010368_abnormal_lymphatic_system | 0.90098730 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 0.89474069 |
| 47 | MP0005409_darkened_coat_color | 0.89405678 |
| 48 | MP0005408_hypopigmentation | 0.89067887 |
| 49 | MP0009642_abnormal_blood_homeostasis | 0.87590756 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.86178425 |
| 51 | MP0008469_abnormal_protein_level | 0.83392480 |
| 52 | MP0005334_abnormal_fat_pad | 0.77730425 |
| 53 | MP0002971_abnormal_brown_adipose | 0.77121888 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.76548440 |
| 55 | MP0001661_extended_life_span | 0.74876435 |
| 56 | MP0009765_abnormal_xenobiotic_induced | 0.73530233 |
| 57 | MP0005448_abnormal_energy_balance | 0.70667115 |
| 58 | MP0005023_abnormal_wound_healing | 0.69594753 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.68902325 |
| 60 | MP0005535_abnormal_body_temperature | 0.67601944 |
| 61 | MP0004130_abnormal_muscle_cell | 0.66603156 |
| 62 | MP0010155_abnormal_intestine_physiology | 0.65384260 |
| 63 | MP0000566_synostosis | 0.64935667 |
| 64 | MP0001664_abnormal_digestion | 0.64458003 |
| 65 | MP0001756_abnormal_urination | 0.63422179 |
| 66 | MP0006138_congestive_heart_failure | 0.62044269 |
| 67 | MP0005266_abnormal_metabolism | 0.60453461 |
| 68 | MP0002249_abnormal_larynx_morphology | 0.60300359 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.57595350 |
| 70 | MP0005330_cardiomyopathy | 0.57272351 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 0.56099038 |
| 72 | MP0009053_abnormal_anal_canal | 0.56070714 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 0.55494289 |
| 74 | MP0000751_myopathy | 0.55057992 |
| 75 | MP0003690_abnormal_glial_cell | 0.54947168 |
| 76 | MP0009384_cardiac_valve_regurgitation | 0.54247065 |
| 77 | MP0002928_abnormal_bile_duct | 0.53890507 |
| 78 | MP0004036_abnormal_muscle_relaxation | 0.52675330 |
| 79 | MP0005395_other_phenotype | 0.51683372 |
| 80 | MP0003953_abnormal_hormone_level | 0.49137144 |
| 81 | MP0003329_amyloid_beta_deposits | 0.49021847 |
| 82 | MP0005666_abnormal_adipose_tissue | 0.48851012 |
| 83 | MP0003724_increased_susceptibility_to | 0.48819611 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 0.48293123 |
| 85 | MP0002822_catalepsy | 0.47785784 |
| 86 | MP0004147_increased_porphyrin_level | 0.47049342 |
| 87 | MP0002060_abnormal_skin_morphology | 0.45904608 |
| 88 | MP0005164_abnormal_response_to | 0.45892825 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.45663980 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.44910289 |
| 91 | MP0001944_abnormal_pancreas_morphology | 0.44436617 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.44026044 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.43924114 |
| 94 | MP0003718_maternal_effect | 0.43900107 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.43150553 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.42866672 |
| 97 | MP0008004_abnormal_stomach_pH | 0.42380704 |
| 98 | MP0001243_abnormal_dermal_layer | 0.42334276 |
| 99 | MP0001915_intracranial_hemorrhage | 0.41959429 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.41708340 |
| 101 | MP0000579_abnormal_nail_morphology | 0.41181990 |
| 102 | MP0001881_abnormal_mammary_gland | 0.40745505 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.40657016 |
| 104 | MP0008873_increased_physiological_sensi | 0.40213169 |
| 105 | MP0009115_abnormal_fat_cell | 0.39613112 |
| 106 | MP0005248_abnormal_Harderian_gland | 0.39414106 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.39296870 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.38736060 |
| 109 | MP0002168_other_aberrant_phenotype | 0.38628245 |
| 110 | MP0008872_abnormal_physiological_respon | 0.38479502 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.38392945 |
| 112 | MP0010386_abnormal_urinary_bladder | 0.37506013 |
| 113 | MP0002796_impaired_skin_barrier | 0.36876779 |
| 114 | MP0000230_abnormal_systemic_arterial | 0.36726198 |
| 115 | MP0003436_decreased_susceptibility_to | 0.35701648 |
| 116 | MP0002269_muscular_atrophy | 0.35680006 |
| 117 | MP0004084_abnormal_cardiac_muscle | 0.35388437 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.35327042 |
| 119 | MP0000678_abnormal_parathyroid_gland | 0.34973318 |
| 120 | MP0005166_decreased_susceptibility_to | 0.33986461 |
| 121 | MP0009672_abnormal_birth_weight | 0.33751892 |
| 122 | MP0002970_abnormal_white_adipose | 0.33553439 |
| 123 | MP0008874_decreased_physiological_sensi | 0.32483460 |
| 124 | MP0003075_altered_response_to | 0.31805085 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.31739991 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.31645900 |
| 127 | MP0000249_abnormal_blood_vessel | 0.30891792 |
| 128 | MP0010234_abnormal_vibrissa_follicle | 0.30703987 |
| 129 | MP0004043_abnormal_pH_regulation | 0.30483377 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.28117463 |
| 131 | MP0002693_abnormal_pancreas_physiology | 0.27633684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.27462255 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.22542179 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.08479648 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57380388 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.44265811 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.37901997 |
| 7 | Xanthomatosis (HP:0000991) | 6.33335288 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.33007057 |
| 9 | Complement deficiency (HP:0004431) | 5.24208237 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.86546643 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.56970683 |
| 12 | Epidermoid cyst (HP:0200040) | 4.53738885 |
| 13 | Joint hemorrhage (HP:0005261) | 4.52151139 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.44704604 |
| 15 | Hyperammonemia (HP:0001987) | 4.36707517 |
| 16 | Fat malabsorption (HP:0002630) | 4.28651283 |
| 17 | Hypoglycemic coma (HP:0001325) | 4.28451460 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.25044707 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.23225404 |
| 20 | Ketosis (HP:0001946) | 4.21003340 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 4.20052928 |
| 22 | Hyperglycinemia (HP:0002154) | 4.19890736 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10138775 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.97838165 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97546101 |
| 26 | Nephritis (HP:0000123) | 3.95149005 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.94844846 |
| 28 | Hyperglycinuria (HP:0003108) | 3.84888432 |
| 29 | Abnormality of complement system (HP:0005339) | 3.82818940 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.78694776 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.78694776 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.63583926 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.51330664 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36993598 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.30433628 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28429877 |
| 37 | Ketoacidosis (HP:0001993) | 3.21224544 |
| 38 | Myocardial infarction (HP:0001658) | 3.07212405 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07206153 |
| 40 | Steatorrhea (HP:0002570) | 3.04496941 |
| 41 | Hypoglycemic seizures (HP:0002173) | 2.98907323 |
| 42 | Skin nodule (HP:0200036) | 2.98779436 |
| 43 | Spontaneous abortion (HP:0005268) | 2.98335001 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.92001573 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.85143897 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.82898163 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.82697875 |
| 48 | Acanthocytosis (HP:0001927) | 2.81690550 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.70938585 |
| 50 | Metabolic acidosis (HP:0001942) | 2.68051901 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.63060888 |
| 52 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.58490614 |
| 53 | Malnutrition (HP:0004395) | 2.56494721 |
| 54 | Vascular calcification (HP:0004934) | 2.50240746 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.48199478 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48199478 |
| 57 | Mitral stenosis (HP:0001718) | 2.48127294 |
| 58 | Gout (HP:0001997) | 2.44542455 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.42969674 |
| 60 | Lethargy (HP:0001254) | 2.40461366 |
| 61 | Glomerulonephritis (HP:0000099) | 2.34082295 |
| 62 | Irritability (HP:0000737) | 2.31941268 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.31257540 |
| 64 | Cholelithiasis (HP:0001081) | 2.30440016 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.30316011 |
| 66 | Hyperglycemia (HP:0003074) | 2.30205409 |
| 67 | Late onset (HP:0003584) | 2.28559565 |
| 68 | Amyloidosis (HP:0011034) | 2.27137207 |
| 69 | Osteomalacia (HP:0002749) | 2.23054540 |
| 70 | Pancreatitis (HP:0001733) | 2.21905654 |
| 71 | Enlarged kidneys (HP:0000105) | 2.21039861 |
| 72 | Spastic diplegia (HP:0001264) | 2.20349873 |
| 73 | Symptomatic seizures (HP:0011145) | 2.20029161 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19315681 |
| 75 | Purpura (HP:0000979) | 2.18889533 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.17645112 |
| 77 | Cholecystitis (HP:0001082) | 2.17645112 |
| 78 | Abnormality of urine glucose concentration (HP:0011016) | 2.14012429 |
| 79 | Glycosuria (HP:0003076) | 2.14012429 |
| 80 | Gingival bleeding (HP:0000225) | 2.12094431 |
| 81 | Facial shape deformation (HP:0011334) | 2.12080152 |
| 82 | Potter facies (HP:0002009) | 2.12080152 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.11942627 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.11942627 |
| 85 | Cerebral edema (HP:0002181) | 2.11115657 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.10011733 |
| 87 | Esophageal varix (HP:0002040) | 2.09622471 |
| 88 | Poikilocytosis (HP:0004447) | 2.08287812 |
| 89 | Menorrhagia (HP:0000132) | 2.07656469 |
| 90 | Brushfield spots (HP:0001088) | 2.07542512 |
| 91 | Neonatal onset (HP:0003623) | 2.06467532 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.04735701 |
| 93 | Rickets (HP:0002748) | 1.99223669 |
| 94 | Opisthotonus (HP:0002179) | 1.98354271 |
| 95 | Renal cortical cysts (HP:0000803) | 1.97732640 |
| 96 | Abnormality of the gallbladder (HP:0005264) | 1.96121392 |
| 97 | Widely patent fontanelles and sutures (HP:0004492) | 1.95984047 |
| 98 | Hypophosphatemia (HP:0002148) | 1.95854588 |
| 99 | Ileus (HP:0002595) | 1.95762093 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 1.95668013 |
| 101 | Vomiting (HP:0002013) | 1.94143783 |
| 102 | Thrombophlebitis (HP:0004418) | 1.93965580 |
| 103 | Nephrolithiasis (HP:0000787) | 1.89777686 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89768390 |
| 105 | Pigmentary retinal degeneration (HP:0001146) | 1.88183607 |
| 106 | Abnormality of the Achilles tendon (HP:0005109) | 1.83559779 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83223100 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 1.82859303 |
| 109 | Elevated alkaline phosphatase (HP:0003155) | 1.80261814 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 1.79697738 |
| 111 | Cerebral palsy (HP:0100021) | 1.78316227 |
| 112 | Hyperphosphaturia (HP:0003109) | 1.78298740 |
| 113 | Abnormality of vitamin metabolism (HP:0100508) | 1.77147818 |
| 114 | Focal segmental glomerulosclerosis (HP:0000097) | 1.77024742 |
| 115 | Elevated hepatic transaminases (HP:0002910) | 1.76952240 |
| 116 | Exercise-induced myalgia (HP:0003738) | 1.75539854 |
| 117 | Proximal tubulopathy (HP:0000114) | 1.74860275 |
| 118 | Increased purine levels (HP:0004368) | 1.74149998 |
| 119 | Reduced antithrombin III activity (HP:0001976) | 1.74135833 |
| 120 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72959597 |
| 121 | Alkalosis (HP:0001948) | 1.71588720 |
| 122 | Protuberant abdomen (HP:0001538) | 1.69491217 |
| 123 | Hyperuricemia (HP:0002149) | 1.67001197 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.65582291 |
| 125 | Fair hair (HP:0002286) | 1.64731182 |
| 126 | Pulmonary embolism (HP:0002204) | 1.62686419 |
| 127 | Abdominal distention (HP:0003270) | 1.56225104 |
| 128 | Glomerulosclerosis (HP:0000096) | 1.53463926 |
| 129 | Arthropathy (HP:0003040) | 1.52948756 |
| 130 | Abnormal delivery (HP:0001787) | 1.50520577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.04224051 |
| 2 | ERN1 | 4.59409696 |
| 3 | SIK1 | 4.46794543 |
| 4 | FGFR4 | 3.99779170 |
| 5 | INSRR | 3.98316488 |
| 6 | TAOK3 | 3.54957998 |
| 7 | MST1R | 3.22982791 |
| 8 | FRK | 2.74211346 |
| 9 | ERBB4 | 2.72218152 |
| 10 | MYLK | 2.48825646 |
| 11 | ACVR1B | 2.41008249 |
| 12 | OBSCN | 2.39234119 |
| 13 | LATS1 | 2.19872915 |
| 14 | FLT3 | 1.92208922 |
| 15 | PKN2 | 1.82465708 |
| 16 | LMTK2 | 1.80646928 |
| 17 | MAPK11 | 1.76743982 |
| 18 | MAP2K4 | 1.76611484 |
| 19 | PTK6 | 1.73905283 |
| 20 | PIK3CG | 1.73082634 |
| 21 | TRIB3 | 1.65631699 |
| 22 | MET | 1.52693074 |
| 23 | ICK | 1.52398616 |
| 24 | MAPK15 | 1.50779626 |
| 25 | TYK2 | 1.43065215 |
| 26 | DDR2 | 1.37407762 |
| 27 | NEK9 | 1.29932389 |
| 28 | CDC42BPA | 1.25739133 |
| 29 | ABL2 | 1.19356420 |
| 30 | PRKAA2 | 1.16941482 |
| 31 | NLK | 1.16728235 |
| 32 | JAK2 | 1.15705910 |
| 33 | DAPK2 | 1.12529984 |
| 34 | PIK3CA | 1.10344586 |
| 35 | EPHA4 | 1.09301715 |
| 36 | FGFR2 | 1.09180648 |
| 37 | EPHA3 | 1.08765243 |
| 38 | JAK1 | 1.05117026 |
| 39 | STK38L | 1.03834294 |
| 40 | MAP3K13 | 1.03602859 |
| 41 | MAPKAPK3 | 1.03057734 |
| 42 | IRAK3 | 1.03045979 |
| 43 | MAP3K7 | 0.99991451 |
| 44 | MAP3K2 | 0.99050492 |
| 45 | PRPF4B | 0.98764715 |
| 46 | MAP3K10 | 0.96768811 |
| 47 | FER | 0.96632815 |
| 48 | EEF2K | 0.90996818 |
| 49 | MAP3K14 | 0.90969019 |
| 50 | ERBB2 | 0.90881310 |
| 51 | KDR | 0.90281150 |
| 52 | PINK1 | 0.88867388 |
| 53 | EPHB1 | 0.88751547 |
| 54 | STK38 | 0.88496332 |
| 55 | PDK1 | 0.87544828 |
| 56 | TBK1 | 0.86854020 |
| 57 | PHKG1 | 0.84289597 |
| 58 | PHKG2 | 0.84289597 |
| 59 | GRK6 | 0.83881688 |
| 60 | TTN | 0.83528227 |
| 61 | MAP2K3 | 0.83082860 |
| 62 | CAMK1D | 0.82662518 |
| 63 | PTK2 | 0.82652367 |
| 64 | RIPK1 | 0.79264079 |
| 65 | MAP3K3 | 0.79199626 |
| 66 | TRPM7 | 0.76097494 |
| 67 | PRKCZ | 0.74568591 |
| 68 | PRKAA1 | 0.73703379 |
| 69 | DYRK1B | 0.71477857 |
| 70 | STK39 | 0.70839200 |
| 71 | GSK3A | 0.70185892 |
| 72 | NUAK1 | 0.68589761 |
| 73 | MAP2K2 | 0.67808074 |
| 74 | PRKACG | 0.66553225 |
| 75 | AKT3 | 0.66010870 |
| 76 | MAPK4 | 0.65145144 |
| 77 | CDK6 | 0.64727441 |
| 78 | MAP3K1 | 0.64640845 |
| 79 | FGFR3 | 0.63648788 |
| 80 | PDK2 | 0.63084342 |
| 81 | MAP2K1 | 0.62644315 |
| 82 | PRKG1 | 0.60932387 |
| 83 | TGFBR2 | 0.60412304 |
| 84 | CSK | 0.59555849 |
| 85 | RET | 0.58096680 |
| 86 | SGK3 | 0.56441091 |
| 87 | PDGFRA | 0.55498551 |
| 88 | CAMK2G | 0.53896442 |
| 89 | TIE1 | 0.53687589 |
| 90 | ZAP70 | 0.53603967 |
| 91 | PDGFRB | 0.53285683 |
| 92 | IRAK1 | 0.49799271 |
| 93 | MAP2K6 | 0.48914539 |
| 94 | MAPK12 | 0.48909300 |
| 95 | IGF1R | 0.48463316 |
| 96 | MUSK | 0.47671070 |
| 97 | NTRK3 | 0.47267402 |
| 98 | ROCK1 | 0.46566971 |
| 99 | PDPK1 | 0.43760513 |
| 100 | OXSR1 | 0.43164308 |
| 101 | PRKCQ | 0.42715448 |
| 102 | CAMK2D | 0.40725939 |
| 103 | MTOR | 0.40463665 |
| 104 | STK24 | 0.40415731 |
| 105 | MAP3K11 | 0.40005433 |
| 106 | SRC | 0.39483703 |
| 107 | MAPK7 | 0.38587530 |
| 108 | STK3 | 0.38361812 |
| 109 | SGK2 | 0.38165283 |
| 110 | PRKACA | 0.38147753 |
| 111 | GRK1 | 0.35209306 |
| 112 | IKBKE | 0.34319668 |
| 113 | PRKG2 | 0.33810177 |
| 114 | CAMK1G | 0.33051061 |
| 115 | AKT2 | 0.32931414 |
| 116 | SGK1 | 0.32445556 |
| 117 | MELK | 0.32388563 |
| 118 | KSR2 | 0.31546765 |
| 119 | EPHB2 | 0.31502135 |
| 120 | MAP3K5 | 0.31475436 |
| 121 | CSF1R | 0.31392583 |
| 122 | CSNK1G1 | 0.30540617 |
| 123 | PRKCH | 0.29801889 |
| 124 | LATS2 | 0.29294832 |
| 125 | PAK3 | 0.28030915 |
| 126 | EPHA2 | 0.27833555 |
| 127 | PRKCA | 0.24876693 |
| 128 | IRAK2 | 0.24687036 |
| 129 | BMX | 0.24225458 |
| 130 | CHUK | 0.24077276 |
| 131 | PKN1 | 0.23760799 |
| 132 | SGK494 | 0.23147379 |
| 133 | SGK223 | 0.23147379 |
| 134 | MAP3K6 | 0.22092295 |
| 135 | ABL1 | 0.21122861 |
| 136 | EGFR | 0.19994673 |
| 137 | CDK4 | 0.19868991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39084971 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45316708 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29842065 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.14846574 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94776647 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73667966 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.68410316 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61485730 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49591720 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48738538 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42660447 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35868443 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20832222 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10592876 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09914574 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04512387 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97131749 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91790320 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88704199 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85935468 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85821010 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85798417 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84883818 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79874913 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73154526 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68723638 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68442851 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66595740 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65983540 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63738202 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60525109 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.59490973 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58743507 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55456423 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.55265499 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53639814 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.51380804 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46516433 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45090251 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41651888 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41647456 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41430632 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31302989 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.31039948 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26887931 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20766780 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18036470 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10054297 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.07610953 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05548729 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98292695 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98157738 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97816852 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92122145 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89074604 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88586030 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88010240 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.85265173 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82310248 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77550240 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75618675 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67265094 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66219046 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64979989 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59301138 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51778010 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51508152 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49665081 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49604020 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45066258 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.41321450 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.38945222 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34735828 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.31790928 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29207824 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28234002 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24047908 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20206440 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13441825 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13355183 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13312094 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11297360 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09767526 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.09587501 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08188430 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06601376 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05130299 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.00661381 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00622671 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00045797 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | -0.1879815 |
| 92 | Protein export_Homo sapiens_hsa03060 | -0.1694097 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1496556 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1480729 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1394310 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | -0.1344730 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1268202 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1182830 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1057826 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1010966 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0919507 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0905152 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0776235 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0697993 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | -0.0504114 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0424567 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0412426 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0400557 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0344715 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0289244 |
| 111 | Renin secretion_Homo sapiens_hsa04924 | -0.0205200 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0098323 |

